Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease

Eric A. Gehrie, Bipin N. Savani, Garrett S. Booth

Research output: Contribution to journalReview articlepeer-review

Abstract

Advances in laboratory testing, pathogen reduction and donor qualification have dramatically reduced the risk of acquiring an infection from a blood transfusion. Despite this progress, the most feared complication of transfusion – a hemolytic reaction due to incompatibility between donor and recipient – remains, with essentially no recent progress in the prevention or recognition of this rare but frequently lethal complication. Herein, the role that compatibility testing and transfusion practice play in the occurrence of acute hemolysis are described, with a special emphasis on clinical scenarios confer an increased risk of a severe hemolytic reaction in response to red blood cell or platelet transfusion. In addition, the signs and symptoms of a severe hemolytic reaction are summarized, along with the initial approach to clinical management.

Original languageEnglish (US)
Article number100719
JournalBlood Reviews
Volume45
DOIs
StatePublished - Jan 2021

Keywords

  • Blood transfusion
  • Hematological emergencies
  • Transfusion reactions

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease'. Together they form a unique fingerprint.

Cite this